Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution

被引：0
|
作者：
Sara Benchikh
Amale Bousfiha
Adil El Hamouchi
Somda Georgina Charlene Soro
Abderrahim Malki
Sanaa Nassereddine
机构：
[1] Pasteur Institute of Morocco,Laboratory of Cytogenetics
[2] Hassan II University,Laboratory of Physiopathology and Molecular Genetics, Faculty of Sciences Ben M’Sik
来源：
Egyptian Journal of Medical Human Genetics | / 23卷
关键词：
CML; Tyrosine kinase; Cytogenetic; Molecular biology; Treatment resistance; Treatment response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Philadelphia-negative chromosomal evolution during treatment for chronic myeloid leukemia
    Hsiao, H. -H.
    Liu, Y. -C.
    Lee, C. -P.
    Chang, C. -S.
    Lin, S. -F.
    GENETICS AND MOLECULAR RESEARCH, 2012, 11 (01) : 317 - 321
  • [32] Karyotype evolution during imatinib treatment in 19 chronic myeloid leukemia patients
    Arghir, A.
    Berbec, N.
    Casleanu, D.
    Lungeanu, A.
    CHROMOSOME RESEARCH, 2005, 13 : 197 - 198
  • [33] MOLECULAR-BIOLOGY STUDIES IN PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOID-LEUKEMIA
    TASSINARI, A
    ZACCARIA, A
    SAGLIO, G
    GUERRASIO, A
    TESTONI, N
    CELSO, B
    ROSTI, G
    CAMBRIN, GR
    TURA, S
    HAEMATOLOGICA, 1988, 73 (04) : 326 - 327
  • [34] Real-World Management of Chronic Myeloid Leukemia in Bosnia and Herzegovina: Treatment Patterns, Molecular Monitoring, and Outcomes
    Kurtovic-Kozaric, Amina
    Islamagic, Erna
    Hasic, Azra
    Mehinovic-Cavcic, Lejla
    Komic, Hana
    Kurtovic, Sabira
    BLOOD, 2022, 140 : 12218 - 12219
  • [35] Impact of quantitative molecular response on the evolution of chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    HEMATOLOGIE, 2006, 12 (04): : 226 - 227
  • [36] Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
    Castellino, Alessia
    Santambrogio, Elisa
    Rapezzi, Davide
    Massaia, Massimo
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [37] MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA DURING INTERFERON TREATMENT
    GRANINGER, W
    MORAWETZ, A
    LINKESCH, W
    SMOLEN, J
    BLUT, 1988, 57 (04): : 194 - 194
  • [38] Deep molecular responses for treatment-free remission in chronic myeloid leukemia
    Dulucq, Stephanie
    Mahon, Francois-Xavier
    CANCER MEDICINE, 2016, 5 (09): : 2398 - 2411
  • [39] Applying Cytogenetic and Molecular Information in the Clinic: Implications for the Treatment of Chronic Myeloid Leukemia
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Cortes, Jorge E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 : S14 - S19
  • [40] Molecular monitoring of chronic myeloid leukemia: a personalized approach to optimizing treatment response
    Nichols, Linda
    Pippnis, Julie
    Castle, Lon
    Cassler, Mary
    Fuller, Courtney
    PERSONALIZED MEDICINE, 2012, 9 (07) : 727 - 737
12345